[1]刘雅南,张操,陆婷,等.自身免疫性多内分泌腺病综合征Ⅱ型合并自身免疫性肝病的病例报道[J].国际内分泌代谢杂志,2022,42(02):157-160.[doi:10.3760/cma.j.cn121383-20201215-12043]
　Liu Yanan,Zhang Cao,Lu Ting,et al.A case report of autoimmune polyendocrine syndromes type 2 complicated with autoimmune liver disease[J].International Journal of Endocrinology and Metabolism,2022,42(02):157-160.[doi:10.3760/cma.j.cn121383-20201215-12043]

点击复制

自身免疫性多内分泌腺病综合征Ⅱ型合并自身免疫性肝病的病例报道()

分享到：

参考文献/References:

[1] Dittmar M,Kahaly GJ.Polyglandular autoimmune syndromes:immunogenetics and long-term follow-up[J].J Clin Endocrinol Metab,2003,88(7):2983-2992.DOI:10.1210/jc.2002-021845.
[2] Frommer L,Kahaly GJ.Autoimmune polyendocrinopathy[J].J Clin Endocrinol Metab,2019,104(10):4769-4782.DOI:10.1210/jc.2019-00602.
[3] Husebye ES,Anderson MS,Kampe O.Autoimmune polyendocrine syndromes[J].N Engl J Med,2018,378(12):1132-1141.DOI:10.1056/NEJMra1713301.
[4] Kahaly GJ,Frommer L.Autoimmune polyglandular diseases[J].Best Pract Res Clin Endocrinol Metab,2019,33(6).DOI:10.1016/j.beem.2019.101344.
[5] Pham-Dobor G,Hanák L,Hegyi P,et al.Prevalence of other autoimmune diseases in polyglandular autoimmune syndromes type Ⅱ and Ⅲ[J].J Endocrinol Invest,2020,43(9):1-9.DOI:10.1007/s40618-020-01229-1.
[6] Schneller C,Finkel L,Wise M,et al.Autoimmune polyendocrine syndrome:a case-based review[J].Pediatr Ann,2013,42(5):203-208.DOI:10.3928/00904481-20130426-12.
[7] Hoener K,Sharma T.Type Ⅱ polyglandular autoimmune syndrome:a case of Addison's disease precipitated by use of levothyroxine[J].BMJ Case Rep,2019,12(8):e230760.DOI:10.1136/bcr-2019-230760.
[8] Inaba H,Ariyasu H,Iwakura H,et al.Autoimmune polyglandular syndrome type 2 and autoimmune hepatitis with thymoma-associated myasthenia gravis:case report[J].BMC Endocr Disord,2020,20(1):47.DOI:10.1186/s12902-020-0498-5.
[9] Kahaly GJ,Frommer L.Polyglandular autoimmune syndromes[J].J Endocrinol Invest,2018,41(1):91-98.DOI:10.1007/s40618-017-0740-9.
[10] Patel T,Nystrom J,Pyrsopoulos N.Autoimmune hepatitis as a part of polyglandular autoim- mune syndrome type II:case report and literature review[J].Dig Dis Sci,2010,55(3):861-864.DOI:10.1007/s10620-009-0796-2.
[11] Hansen MP,Matheis N,Kahaly GJ.Type 1 diabetes and polyglandular autoimmune syndrome:a review[J].World J Diabetes,2015,6(1):67-79.DOI:10.4239/wjd.v6.i1.67.
[12] Betterle C,Dal Pra C,Mantero F,et al.Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes:autoantibodies,autoantigens,and their applicability in diagnosis and disease prediction[J].Endocr Rev,2002,23(3):327-364.DOI:10.1210/edrv.23.3.0466.
[13] Yu L,Brewer KW,Gates S,et al.DRB1*04 and DQ alleles:expression of 21-hydroxylase autoantibodies and risk of progression to Addison's disease[J].J Clin Endocrinol Metab,1999,84(1):328-335.DOI:10.1210/jcem.84.1.5414.
[14] 廖二元,袁凌青.内分泌代谢病学[M].北京:人民卫生出版社,2019:1080-1083.
[15] Shaikh MG,Lewis P,Kirk JM.Thyroxine unmasks Addison's disease[J].Acta Paediatr,2004,93(12):1663-1665.DOI:10.1111/j.1651-2227.2004.tb00860.x.